Furthermore, a recent study revealed that ADAMTS-5 also cleaves inter-α-inhibitor and releases active heavy chain 2, which is detectable in synovial fluids from both RA and OA patients, and may contribute to the progression of arthritis beyond the degradation of aggrecan [25]. Here, ACAN is linked to arthritic joint disease.